返回
Infant Bacterial Therapeutics AB (publ)（IFTBF）價格
IFTBF 股價走勢圖
IFTBF 財務
Infant Bacterial Therapeutics AB (publ)
$5.47
14.43%
$0.68
收盤價：Jan 21, 16:00:00 GMT-5
$5.47
0%
$0
盤後：Jan 21, 19:52:59 GMT-5
收入
資產負債表
現金流量
年度
每季
IFTBF 收入
財務數據以百萬美元計。會計年度為二月至一月。
Follow-Up Questions
Infant Bacterial Therapeutics AB (publ) 的關鍵財務報表是什麼？
IFTBF 的關鍵財務比率是什麼？
Infant Bacterial Therapeutics AB (publ) 的收入按細分市場或地理位置如何劃分？
Infant Bacterial Therapeutics AB (publ) 是否盈利？
Infant Bacterial Therapeutics AB (publ) 有負債嗎？
Infant Bacterial Therapeutics AB (publ) 的流通股有多少？
關鍵數據
前收市價
$4.78
開盤價
$5.47
當日範圍
$5.47 - $5.47
52週區間
$4.78 - $8.2
交易量
--
平均成交量
1.0K
每股盈餘 (TTM)
--
股息收益率
--
市值
--
什麼是 INFANT BACTERIAL THERAPEUTICS A？
Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. The company is headquartered in Stockholm, Stockholm and currently employs 10 full-time employees. The company went IPO on 2016-03-29. The firm develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.